Funding for the Ocular Gene Therapy Laboratory
Active Grant Support for the Ocular Gene Therapy Laboratory
 |
National Eye Institute Research Project Grant (R01EY027767) ‘Vascular Gene Delivery and Early Disease Biomarkers in Diabetic Retinopathy’ 09/30/2018 – 08/31/2023 PI: Lipinski |
 |
Foundation Fighting Blindness Program Project Award (PPA-0617-0718-UCSF) |
| |
National Eye Institute Audacious Goals Initiative (U24EY029891) ‘Developing Cone-Dominant retinal disease models as a resource for translations vision research’ 09/30/2018 – 08/31/2023 MPI: Carroll/Duncan Role: Co-investigator |
| |
Foundation Fighting Blindness Individual Investigator Award (TA-NMT-0618-0739-MCW) ‘Maintaining Proteostasis to Prevent Photoreceptor Degeneration in Retinal Disease’ 06/01/2018 – 05/31/2021 Role: PI |
 |
Philanthropic Support ‘Anonymous’ ‘Robert A. Brandt Macular Degeneration Fund’ |
Completed Grant Support for the Ocular Gene Therapy Laboratory
 |
Glaucoma Research Foundation Shaffer Award ‘Development of rAAV Technologies to Facilitate Topical Gene Delivery to the Cornea’ 03/05/2019 – 03/04/2020 PI: Lipinski |
 |
Juvenile Diabetes Research Foundation Innovative Grant (1-PNF-20140120-A-N) ‘Validation of Novel AAV vector for Target Gene Therapy to Prevent Vascular Complications of Diabetic Retinopathy’ 05/01/2014 – 10/31/2015 PI: Lipinski |